약력
이화여자대학교 의학과 석사
이대목동병원 인턴
이대목동병원 신경과 전공의
서울대학교병원 신경과 전임의
서울대학교병원 신경과 연구 전임의
미국 콜롬비아대학교 메디컬센터 연수
건국대학교병원 신경과 전임의
건국대학교병원 신경과 조교수
건국대학교병원 신경과 부교수
명주병원 신경과 진료과장
[학회]
대한치매학회 정회원
대한 파킨슨병 및 이상운동질환 학회 정회원
대한신경과학회 정회원
현) 나은병원 신경과 과장
[논문]
1. Nam SK, Yoo D, Lee W-W, Jang M, Kim HJ, Kim YE, et al. Patient selected goals and satisfaction after bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease. J Clin Neurosci. 2020 Jun;76:148-153.
2. Choi JH, Lee JY, Cho JW, Ko SB, Ahn TB, Kim SJ, et al. Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease Rating Scale. J Clin Neurol. 2020 Apr;16(2):245-253.
3. Yang H-J, Kim HJ, Ko SB, Kim JS, Ahn TB, Cheon SM, et al. Subtypes of Sleep Disturbance in Parkinson’s Disease Based on the Cross-Culturally Validated Korean Version of Parkinson’s Disease Sleep Scale-2. J Clin Neurol. 2020 Jan;16(1):66-74.
4. Kim HJ, Jeon B. Decision under risk: Argument against early deep brain stimulation in Parkinson’s disease. Parkinsonism Relat Disord. 2019 Dec;69:7-10.
5. Kim R, Yoo D, Jung YJ, Lee W-W, Ehm G, Yun JY, Kim HJ, et al. Determinants of Functional Independence or Its Loss following Subthalamic Nucleus Stimulation in Parkinson’s Disease. Stereotact Funct Neurosurg. 2019;97(2):106-112
6. Ehm G, Kim H-J, Kim J-Y, Lee J-Y, Kim HJ, Yun JY, et al. Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson’s disease: 7-year follow-up. J Neurosurg. 2018 Nov 1;1-6.
7. Park J, Koh SB, Kim HJ, Oh E, Kim JS, Yun JY, et al. Validity and Reliability Study of the Korean Tinetti Mobility Test for Parkinson’s Disease. J Mov Disord. 2018 Jan;11(1):24-29
8. Sung YH, Kim HJ, Koh SB, Kim JS, Kim SJ, Cheon SM, et al. Validation of the Korean Version of the Scales for Outcomes in Parkinson’s Disease-Sleep. J Korean Med Sci. 2018 Jan 8;33(2):e14
9. Kim HJ, Jeon BS, Jenner P. Hallmarks of Treatment Aspects: Parkinson’s Disease Throughout Centuries Including L-Dopa. Int Rev Neurobiol. 2017;132:295-343.
10. Kim JY, Song IU, Koh SB, Ahn TB, Kim SJ, Cheon SM, et al. Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic. J Mov Disord. 2017 Jan;10(1):29-34.
11. Kim HJ, Jeon B, Chung SJ. Professional ethics in complementary and alternative medicines in management of Parkinson’s disease. J Parkinsons Dis. 2016 Oct 19;6(4):675-683.
12. Kwon DY, Koh SB, Lee JH, Park HK, Kim HJ, Shin HW, et al. The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson’s Disease NATION Study Group. J Clin Neurol. 2016 Oct;12(4):393-402.
13. Moon WJ, Park JY, Yun WS, Jeon JY, Moon YS, Kim H, et al. A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson’s Disease Dementia, Alzheimer’s Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging. Korean J Radiol 2016 Sep-Oct;17(5):633-40.
14. Mun JK, Youn J, Cho JW, Oh ES, Kim JS, Park S, et al. Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naïve Parkinson’s Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study. PLoS One. 2016 Sep 13;11(9):e0162254.
15. Kim HJ, Jeon B. How close are we to individualized medicine for Parkinson’s disease? Expert Rev Neurother. 2016 Jul;16(7):815-30.
16. Lee HJ, Kim SK, Park H, Kim HB, Jeon HS, Jung YJ, Oh E, Kim HJ, Yun JY, Jeon BS, Park KS. Clinicians’ Tendencies to Under-Rate Parkinsonian Tremors in the Less Affected Hand. PLoS One. 2015 Jun 25;10(6):e0131703.
17. Kim YE, Jeon BS, Paek SH, Yun JY, Yang HJ, Kim HJ, Ehm G, Kim HJ, Lee JY, Kim JY. Rapid eye movement sleep behavior disorder after bilateral subthalamic stimulation in Parkinson’s disease. J Clin Neurosci. 2015 Feb;22(2):315-9.
18. Yun JY, Kim JM, Kim HJ, Lee JY, Kim HJ, Kim JS, Kim YK, Kim SE, Ahn TB, Jeon BS. Parkinsonism in corticobasal syndrome may not be primarily due to presynaptic dopaminergic deficiency. Neurology Asia 2015;20 (1):23-27
19. Kim HJ, Yun JY, Kim YE, Lee JY, Kim HJ, Kim JY, Park SS, Paek SH, Jeon BS. Parkin mutation and deep brain stimulation outcome. J Clin Neurosci. 2014 Jan;21(1):107-10.
20. Kim HJ, Jeon BS, Paek SH, Lee KM, Kim JY, Lee JY, Kim HJ, Yun JY, Kim YE, Yang HJ, Ehm G. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease. J Neurol. 2014 Jun;261(6):1090-6.
21. Kim HJ, Jeon BS. Is acupuncture efficacious therapy in Parkinson’s disease? J Neurol Sci. 2014 Jun 15;341(1-2):1-7.
22. Kim YE, Kim HJ, Kim HJ, Lee JY, Yun JY, Kim JY, Paek SH, Jeon BS. Impulse control and related behaviors after bilateral subthalamic stimulation in patients with Parkinson’s disease. J Clin Neurosci. 2013;20(7):964-969
23. Kim HJ, Jeon BS, Kim SH, Han SH. Reversible antecollis associated with pramipexole in a patient with Parkinson’s disease. J Clin Neurosci. 2012 Jun;19(6):903-4.
24. Yun JY, Lee WW, Kim HJ, Kim JS, Kim JM, Kim HJ, Kim SY, Kim JY, Park SS, Kim YK, Kim SE, Jeon BS. Relative contribution of SCA2, SCA3 and SCA17 in Korean patients with parkinsonism and ataxia. Parkinsonism Relat Disord. 2011;17:338-342
25. Kim HJ, Kim JH, Park KD, Choi KG, Lee HW. A survey of sleep deprivation patterns and their effects on cognitive functions of residents and interns in Korea. Sleep Med. 2011;12(4):390-6.
26. Kim HJ, Yun JY, Kim JM, Kim YK, Erm G, Kim SE, Jeon BS. Extranigral extension of structural midbrain lesions overshadows Parkinsonism. J Neural Transm 2011 Feb 5. (2011) 118:1209–1213.
27. Kim HJ, Kim HJ, Lee JY, Yun JY, Kim SY, Park SS, Jeon BS. Phenotype analysis in patients with early-onset Parkinson’s disease with and without parkin mutations. J Neuol (2011) 258:2260–2267.
28. Kim HJ, Kim JM, Lee JY, Park SS, Jeon BS. α-Synuclein polymorphism and Parkinson’s disease in a tau homogeneous population. Neurology Asia 2010;15(1) :61–63
29. Kim JM, Lee JY, Kim HJ, Kim JS, Kim YK, Park SS, Kim SE, Jeon BS. The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6. JNNP 2010;81:529-532
30. Yun JY, Lee WW, Lee JY, Kim HJ, Park SS, Jeon BS. SNCA variants and multiple system atrophy. Ann Neurol. 2010;67(4):554-5.
31. Kim JM, Lee JY, Kim HJ, Kim JS, Shin ES, Cho JH, Park SS, Jeon BS. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson’s disease in the Korean population. Parkinsonism Relat Disord. 2010;16:85–88
32. Kim HJ, Jeon BS. Acute respiratory failure due to vocal cord paralysis in a patient with Parkinson’s disease. Mov Disord. 2009:15;24(12):1862-3.
33. Lee JY, Lee WW, Kim JS, Kim HJ, Kim JK, Jeon BS. Perverted head-shaking and positional downbeat nystagmus in patients with multiple system atrophy. Mov Disord. 2009 15;24(9):1290-5.
34. Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson’s disease. Mov Disord. 2009 15;24(12):1803-10.
35. Lee WW, Kim SY, Kim JY, Kim HJ, Park SS, Jeon BS. Extrapyramidal signs are a common feature of Spinocerebellar ataxia type 17. Neurology 2009;17;73(20):1708-9.